NCT00333021 is a Phase 3 clinical trial of Fondaparinux sodium in Venous Thromboembolism, sponsored by GlaxoSmithKline.

Who is sponsoring NCT00333021?

NCT00333021 is sponsored by GlaxoSmithKline.

What drugs are being tested in NCT00333021?

Interventions in NCT00333021: Fondaparinux sodium, GSK576428.

What condition does NCT00333021 study?

NCT00333021 studies Venous Thromboembolism.

Is NCT00333021 still recruiting?

NCT00333021 is currently completed. Last updated 9 July 2009.

Last reviewed 2009-07-09 · How we verify

NCT00333021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery

Completed Phase 3 Last updated 9 July 2009

What this trial tests

Phase 3 trial testing Fondaparinux sodium in Venous Thromboembolism in 127 participants. Completed in 1 February 2007.

Timeline

1 May 2006

1 February 2007

Quick facts

Lead sponsor	GlaxoSmithKline
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	127
Start date	1 May 2006
Estimated completion	1 February 2007
Sites	18 locations across Japan

Drugs / interventions tested

Fondaparinux sodium — full drug profile →
GSK576428 — full drug profile →

Conditions studied

Venous Thromboembolism — all drugs for Venous Thromboembolism →

Sponsor

GlaxoSmithKline — full company profile →

Who can join

40 and older, any sex, with Venous Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Incidence of Venous thromboembolism and Major bleeding
Time frame: Throughout entire study

Sponsor's own description

This study is phase 3 study for prevention of VTE in patients with abdominal surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Graduated compression stockings for prevention of deep vein thrombosis.
Sachdeva A, Dalton M, Lees T. · · 2018 · cited 70× · PMID 30390397 · DOI 10.1002/14651858.cd001484.pub4

Verify or expand the search:

Other recruiting trials for Venous Thromboembolism

Currently open trials in the same condition.

NCT07399977 — Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism · NA · recruiting
NCT06861088 — The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer · Phase 3 · recruiting
NCT07140523 — A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA · Phase 2 · recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT06440694 — Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) · Phase 3 · recruiting

Other GlaxoSmithKline trials

Trials by the same sponsor.

NCT07569081 — A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflam · Phase 2, PHASE3 · not yet recruiting
NCT07406347 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose · Phase 1 · not yet recruiting
NCT07286266 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEH · Phase 3 · not yet recruiting
NCT07286331 — A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-E · Phase 3 · not yet recruiting
NCT07406334 — A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00333021 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GlaxoSmithKline
Last refreshed: 9 July 2009

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00333021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing